|
Name |
2-Aminophenylacetic acid
|
Molecular Formula | C8H9NO2 | |
IUPAC Name* |
2-(2-aminophenyl)acetic acid
|
|
SMILES |
C1=CC=C(C(=C1)CC(=O)O)N
|
|
InChI |
InChI=1S/C8H9NO2/c9-7-4-2-1-3-6(7)5-8(10)11/h1-4H,5,9H2,(H,10,11)
|
|
InChIKey |
KHMNCHDUSFCTGK-UHFFFAOYSA-N
|
|
Synonyms |
2-Aminophenylacetic acid; 3342-78-7; 2-(2-aminophenyl)acetic acid; (2-Aminophenyl)acetic acid; Benzeneacetic acid, 2-amino-; MFCD03701521; 2-aminophenylaceticacid; 2-Aminophenacetic acid; (2-Amino-phenyl)-acetic acid; 2-amino-benzeneacetic acid; 2-amino-phenyl-acetic acid; SCHEMBL72851; Discontinued See I627300; (2-Aminophenyl)acetic acid #; O-AMINOPHENYLACETIC ACID; DTXSID50342684; CHEBI:149652; ACT09016; ZINC2509868; (2-Aminophenyl)acetic acid AldrichCPR; AKOS000104761; AB15776; AM83001; (2-Aminophenyl)acetic acid, AldrichCPR; AS-32912; SY101243; DB-020543; BB 0244246; FT-0634786; EN300-64160; 342A787; A821769; 2,5-PYRIDINEDICARBOXYLICACIDDI-N-PROPYLESTER; J-500636
|
|
CAS | 3342-78-7 | |
PubChem CID | 583776 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 151.16 | ALogp: | 0.7 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 63.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.626 |
Caco-2 Permeability: | -5.127 | MDCK Permeability: | 0.00017769 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.152 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.305 | Plasma Protein Binding (PPB): | 43.57% |
Volume Distribution (VD): | 0.259 | Fu: | 61.71% |
CYP1A2-inhibitor: | 0.034 | CYP1A2-substrate: | 0.083 |
CYP2C19-inhibitor: | 0.041 | CYP2C19-substrate: | 0.153 |
CYP2C9-inhibitor: | 0.033 | CYP2C9-substrate: | 0.85 |
CYP2D6-inhibitor: | 0.024 | CYP2D6-substrate: | 0.379 |
CYP3A4-inhibitor: | 0.01 | CYP3A4-substrate: | 0.153 |
Clearance (CL): | 7.114 | Half-life (T1/2): | 0.808 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.232 |
Drug-inuced Liver Injury (DILI): | 0.931 | AMES Toxicity: | 0.315 |
Rat Oral Acute Toxicity: | 0.13 | Maximum Recommended Daily Dose: | 0.009 |
Skin Sensitization: | 0.705 | Carcinogencity: | 0.164 |
Eye Corrosion: | 0.457 | Eye Irritation: | 0.963 |
Respiratory Toxicity: | 0.126 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000409 | 0.667 | D07HBX | 0.425 | ||||
ENC000054 | 0.526 | D0TG1H | 0.407 | ||||
ENC000043 | 0.523 | D0R1CR | 0.400 | ||||
ENC000160 | 0.465 | D05EJG | 0.385 | ||||
ENC000303 | 0.463 | D0Y7EM | 0.382 | ||||
ENC000108 | 0.425 | D0U1OM | 0.371 | ||||
ENC000004 | 0.419 | D01ZJK | 0.356 | ||||
ENC000219 | 0.415 | D0GY5Z | 0.354 | ||||
ENC005854 | 0.415 | D07ONP | 0.347 | ||||
ENC000013 | 0.410 | D0X9RY | 0.341 |